Randomized controlled trial2014

Effect of lowering the glycemic load with canola oil on glycemic control and cardiovascular risk factors: a randomized controlled trial

Jenkins DJ, Kendall CW, Vuksan V, Faulkner D, Augustin LS, Mitchell S, Ireland C, Srichaikul K, Mirrahimi A, Chiavaroli L, Blanco Mejia S, Nishi S, Sahye-Pudaruth S, Patel D, Bashyam B, Vidgen E, de Souza RJ, Sievenpiper JL, Coveney J, Josse RG, Leiter LA

Diabetes care · 68 citations

Review labels

Controlled feedingFunding not disclosed

Neutral facts our review recorded about how this study was done. They describe method, never whether we like the result.

How it was studied

Design
Randomized controlled trial (indexed by PubMed)
Studied in
People
Main outcome
Health markers and function
Intake measured by
Food provided by researchers

Who paid for it

Funding
Funding not disclosed

Publication

Published
2014-06-12 · Diabetes Care · vol. 37 · issue 7 · pp. 1806–1814
Publisher
American Diabetes Association
Cited
98 citations · more than 96% of similar papers · 5.6× the field average
Impact
Top 10% most cited in its field
References
39 works
Access
Open access (repository copy) · CC-BY-NC-ND
Research areas
Fatty Acid Research and Health · Nutritional Studies and Diet · Coconut Research and Applications
Keywords
Medicine, Glycemic, Internal medicine, Diabetes mellitus, Type 2 diabetes, Glycemic load, Randomized controlled trial, Glycemic index, Canola, Framingham Risk Score, Blood pressure, Gastroenterology, Endocrinology, Food science, Disease
MeSH
humans, cardiovascular diseases, diabetes mellitus, type 2, blood glucose, fatty acids, monounsaturated, hypoglycemic agents, diet, risk factors, energy intake, blood pressure, aged, middle aged, canada, female, male, edible grain, rapeseed oil

21 authors

From CA

  • David J.A. JenkinsSt. Michael's Hospital; University of Toronto
  • Cyril W.C. KendallSt. Michael's Hospital; University of Toronto; University of Saskatchewan
  • Vladimir V.V. VuksanSt. Michael's Hospital; University of Toronto
  • Dorothea A. FaulknerSt. Michael's Hospital; University of Toronto
  • Livia S. A. AugustinSt. Michael's Hospital
  • Sandra A. MitchellSt. Michael's Hospital; University of Toronto

Abstract

Objective

Despite their independent cardiovascular disease (CVD) advantages, effects of α-linolenic acid (ALA), monounsaturated fatty acid (MUFA), and low-glycemic-load (GL) diets have not been assessed in combination. We therefore determined the combined effect of ALA, MUFA, and low GL on glycemic control and CVD risk factors in type 2 diabetes.

Research design and methods

The study was a parallel design, randomized trial wherein each 3-month treatment was conducted in a Canadian academic center between March 2011 and September 2012 and involved 141 participants with type 2 diabetes (HbA1c 6.5%-8.5% [48-69 mmol/mol]) treated with oral antihyperglycemic agents. Participants were provided with dietary advice on either a low-GL diet with ALA and MUFA given as a canola oil-enriched bread supplement (31 g canola oil per 2,000 kcal) (test) or a whole-grain diet with a whole-wheat bread supplement (control). The primary outcome was HbA1c change. Secondary outcomes included calculated Framingham CVD risk score and reactive hyperemia index (RHI) ratio.

Results

Seventy-nine percent of the test group and 90% of the control group completed the trial. The test diet reduction in HbA1c units of -0.47% (-5.15 mmol/mol) (95% CI -0.54% to -0.40% [-5.92 to -4.38 mmol/mol]) was greater than that for the control diet (-0.31% [-3.44 mmol/mol] [95% CI -0.38% to -0.25% (-4.17 to -2.71 mmol/mol)], P = 0.002), with the greatest benefit observed in those with higher systolic blood pressure (SBP). Greater reductions were seen in CVD risk score for the test diet, whereas the RHI ratio increased for the control diet.

Conclusions

A canola oil-enriched low-GL diet improved glycemic control in type 2 diabetes, particularly in participants with raised SBP, whereas whole grains improved vascular reactivity.

Abstract via Europe PMC. Copyright remains with the authors or publisher.

Community trust

Loading…

How much do you trust this study's findings?

0 · not at all10 · completely

Comments

Sign in to rate, comment on or flag this study.Sign in

Something wrong here?

Flag this study if its information, labels or funding look wrong. An editor reviews every flag.

Sign in to rate, comment on or flag this study.Sign in

Educational information about published research. Not medical advice, and not a recommendation to start or stop anything.